Eli Lilly's Zepbound and Mounjaro now available in U.S. after shortages, FDA says
August 02, 2024 at 16:22 PM EDT
Demand for weight loss and diabetes drugs has trounced supply for months, pushing Eli Lilly and its rival Novo Nordisk to invest billions to ramp up manufacturing.
